Top

Published in:

14-07-2023 | Prostatectomy | Original Article

Outcomes of thulium prostatectomy with “Oyster technique” versus transurethral prostatectomy (TURP): a randomized control trial

Authors: Dimitrios Kotsiris, Vasileios Tatanis, Angelis Peteinaris, Vasileios Tzenetidis, Konstantinos Pagonis, Panteleimon Ntasiotis, Constantinos Adamou, Theofanis Vrettos, Evangelos Liatsikos, Panagiotis Kallidonis

Published in: World Journal of Urology | Issue 9/2023

Abstract

Purpose

To compare the perioperative and postoperative outcomes between Oyster prostate vaporesection using Tm−YAG laser and the conventional transurethral prostatectomy using monopolar energy.

Methods

Patients with LUTS with an accumulative size of at least 60 ml were randomly assigned to one of two parallel groups to undergo Tm-YAG laser vaporesection (Group 1) or conventional monopolar transurethral prostatectomy (Group 2). The primary endpoints were the reduction in IPSS and the increase in Qmax postoperatively. Secondary endpoints included the Hemoglobin drop, the complication rate, the changes in urodynamic parameters, the duration of hospitalization and catheterization and the changes in IIEF during the 24-month follow-up.

Results

In total 32 and 30 patients were enrolled in Groups 1 and 2, respectively. Patient age (p = 0.422) and prostate volume were similar among the groups (p = 0.51). The outcomes in terms of IPSS decrease and Qmax amelioration were comparable (p = 0.449 and p = 0.237, respectively). Operative and hospitalization times were lower in Group 1 (p = 0.002 and p = 0.004, respectively). Hemoglobin drop, changes in urodynamic parameters and improvement in IIEF and QoL scores did not differ among the two Groups. The average time with the catheter was 2.06 ± 0.35 and 2.5 ± 0.82 (p = 0.003) days for Group 1 and Group 2, respectively. The overall complication rate was 6.2% for Group 1 and 13.3% for Group 2.

Conclusions

The Oyster technique leads to similar postoperative outcomes compared to the standard monopolar transurethral prostatectomy. The shorter catheterization, hospitalization and operation time should be considered advantages of the Oyster technique.

Robert G, De La Taille A, Descazeaud A (2018) Epidemiology of benign prostatic hyperplasia. Progres Urol: J Assoc Fr Urol Soc Fr Urol 28(15):803–812CrossRef

Foo KT (2019) What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)? World J Urol 37(7):1293–1296CrossRefPubMedPubMedCentral

Gravas S, Gacci M, Gratzke C, Herrmann TRW, Mamoulakis C, Rieken M, Speakman MJ, Tikkinen KAO (2020) EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. Benign prostatic obstruction (BPO). EAU guidelines, pp 34–5

Ho HS, Yip SK, Lim KB, Fook S, Foo KT, Cheng CW (2007) A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol 52(2):517–522CrossRefPubMed

Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TR et al (2012) Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 61(2):317–325CrossRefPubMed

Deininger S, Herrmann T, Schönburg S, Törzsök P, Kunit T, Lusuardi L (2020) Surgical treatment of benign prostatic obstruction (BPO) in patients under anticoagulation: a review of the bleeding risks of established techniques. Der Urologe Ausg A 59(10):1187–1194CrossRefPubMedPubMedCentral

Bach T, Wendt-Nordahl G, Michel MS, Herrmann TR, Gross AJ (2009) Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate. World J Urol 27(4):541–545CrossRefPubMed

Bach T, Netsch C, Pohlmann L, Herrmann TR, Gross AJ (2011) Thulium:YAG vapoenucleation in large volume prostates. J Urol 186(6):2323–2327CrossRefPubMed

Becker B, Orywal AK, Gross AJ, Netsch C (2019) Thulium vapoenucleation of the prostate (ThuVEP) for prostates larger than 85 ml: long-term durability of the procedure. Lasers Med Sci 34(8):1637–1643CrossRefPubMed

10.

Netsch C, Magno C, Butticè S, Macchione L, Mucciardi G, Herrmann TR et al (2016) Thulium Vaporesection of the prostate and thulium vapoenucleation of the prostate in patients on oral anticoagulants: a retrospective three-centre matched-paired comparison. Urol Int 96(4):421–426CrossRefPubMed

11.

Sener TE, Butticè S, Macchione L, Netsch C, Tanidir Y, Dragos L et al (2017) Thulium laser vaporesection of the prostate: Can we operate without interrupting oral antiplatelet/anticoagulant therapy? Investig Clin Urol 58(3):192–199CrossRefPubMedPubMedCentral

12.

Carmignani L, Macchi A, Ratti D, Finkelberg E, Casellato S, Maruccia S et al (2015) One day surgery in the treatment of benign prostatic enlargement with thulium laser: a single institution experience. Korean J Urol 56(5):365–369CrossRefPubMedPubMedCentral

13.

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213CrossRefPubMedPubMedCentral

14.

Bozzini G, Seveso M, Melegari S, de Francesco O, Buffi NM, Guazzoni G et al (2017) Thulium laser enucleation (ThuLEP) versus transurethral resection of the prostate in saline (TURis): a randomized prospective trial to compare intra and early postoperative outcomes. Actas Urol Esp 41(5):309–315CrossRefPubMed

15.

Peng B, Wang GC, Zheng JH, Xia SQ, Geng J, Che JP et al (2013) A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia. BJU Int 111(4):633–637CrossRefPubMed

16.

Cui D, Sun F, Zhuo J, Sun X, Han B, Zhao F et al (2014) A randomized trial comparing thulium laser resection to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: four-year follow-up results. World J Urol 32(3):683–689CrossRefPubMed

17.

Castellani D, Di Rosa M (2020) Thulium laser vapoenucleation of the prostate (ThuVEP) in men at high cardiovascular risk and on antithrombotic therapy: a single-center experience. J Clin Med 9(4):917CrossRefPubMedPubMedCentral

18.

Xia SJ, Zhuo J, Sun XW, Han BM, Shao Y, Zhang YN (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53(2):382–389CrossRefPubMed

19.

Vargas C, Garcia-Larrosa A, Capdevila S, Laborda A (2014) Vaporization of the prostate with 150-w thulium laser: complications with 6-month follow-up. J Endourol 28(7):841–845CrossRefPubMedPubMedCentral

20.

Feng L, Zhang D, Tian Y, Song J (2016) Thulium laser enucleation versus plasmakinetic enucleation of the prostate: a randomized trial of a single center. J Endourol 30(6):665–670CrossRefPubMed

21.

Yang Z, Liu T, Wang X (2016) Comparison of thulium laser enucleation and plasmakinetic resection of the prostate in a randomized prospective trial with 5-year follow-up. Lasers Med Sci 31(9):1797–1802CrossRefPubMed

22.

Enikeev D, Glybochko P, Rapoport L, Okhunov Z, O’Leary M, Potoldykova N et al (2018) Impact of endoscopic enucleation of the prostate with thulium fiber laser on the erectile function. BMC Urol 18(1):87CrossRefPubMedPubMedCentral

23.

Tiburtius C, Knipper S, Gross AJ, Netsch C (2014) Impact of thulium vapoenucleation of the prostate on erectile function: a prospective analysis of 72 patients at 12-month follow-up. Urology 83(1):175–180CrossRefPubMed

24.

Morozov A, Taratkin M, Kozlov V, Tarasov A, Bezrukov E, Enikeev M et al (2020) Retrospective assessment of endoscopic enucleation of prostate complications: a single-center experience of more than 1400 patients. J Endourol 34(2):192–197CrossRefPubMed

25.

Rijo E, Misrai V, Aho T, Gomez-Sancha F (2018) Recommendations for safe and efficient morcellation after endoscopic enucleation of the prostate. Urology 121:197CrossRefPubMed

Title: Outcomes of thulium prostatectomy with “Oyster technique” versus transurethral prostatectomy (TURP): a randomized control trial
Authors: Dimitrios Kotsiris
Vasileios Tatanis
Angelis Peteinaris
Vasileios Tzenetidis
Konstantinos Pagonis
Panteleimon Ntasiotis
Constantinos Adamou
Theofanis Vrettos
Evangelos Liatsikos
Panagiotis Kallidonis
Publication date: 14-07-2023
Publisher: Springer Berlin Heidelberg
Keywords: Prostatectomy
Prostatectomy
Transurethral Prostate Resection
Urethral Stricture
Laser
Published in: World Journal of Urology / Issue 9/2023
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-023-04510-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Outcomes of thulium prostatectomy with “Oyster technique” versus transurethral prostatectomy (TURP): a randomized control trial

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2023

Long-term oncologic and functional outcomes following robot-assisted radical cystectomy and intracorporeal Padua ileal bladder: results from a single high-volume center

Can Chat-GPT a substitute for urological resident physician in diagnosing diseases?: a preliminary conclusion from an exploratory investigation

Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial

The Rho-kinase inhibitor Y27632 promotes ureteral relaxation in an in vivo rat model for partial ureteral obstruction

A Delphi consensus to standardize the technique of anatomical endoscopic enucleation of prostate: a study by ESUT endoscopic enucleation of prostate study group

Letter to the editor for the article “Real-world outcomes of first-line chemotherapy for unresectable stage III and IV bladder cancer”